Evidence for decreased expression and activity of phosphatase inhibitor-1 in human heart failure

被引：0
|
作者：
Pamminger, T
El-Armouche, A
Eschenhagen, T
机构：
[1] Univ Erlangen Nurnberg, Dept Pharmacol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Toxicol, D-91054 Erlangen, Germany
[3] Univ Hamburg, Klinikum Eppendorf, D-20246 Hamburg, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
349
引用
收藏
页码：R91 / R91
页数：1
相关论文
共 50 条
  • [1] Evidence for phosphatase inhibitor-1 playing a role in β-adrenergic desensitization observed in heart failure
    El-Armouche, A
    Jaeckel, E
    Pamminger, T
    Eschenhagen, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R88 - R88
  • [2] Reduced expression of protein phosphatase inhibitor-1 in human heart failure and functional consequences of its overexpression in cardiac myocytes
    El-Armouche, A
    Rau, T
    Zimmermann, WH
    Zolk, O
    Harding, SE
    Boknik, P
    Eschenhagen, T
    CIRCULATION, 2001, 104 (17) : 1 - 1
  • [3] EVIDENCE FOR ISOPROTERENOL-INDUCED PHOSPHORYLATION OF PHOSPHATASE INHIBITOR-1 IN THE INTACT HEART
    NEUMANN, J
    GUPTA, RC
    SCHMITZ, W
    SCHOLZ, H
    NAIRN, AC
    WATANABE, AM
    CIRCULATION RESEARCH, 1991, 69 (06) : 1450 - 1457
  • [4] EXPRESSION OF PHOSPHATASE INHIBITOR-1 IN CARDIAC TISSUE
    NEUMANN, J
    ESCHENHAGEN, T
    SCHMITZ, W
    SCHOLZ, H
    FASEB JOURNAL, 1993, 7 (03): : A113 - A113
  • [5] Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts
    El-Armouche, A
    Pamminger, T
    Ditz, D
    Zolk, O
    Eschenhagen, T
    CARDIOVASCULAR RESEARCH, 2004, 61 (01) : 87 - 93
  • [6] Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts
    El-Armouche, A
    Pamminger, T
    Ditz, D
    Zolk, O
    Eschenhagen, T
    CIRCULATION, 2003, 108 (17) : 116 - 116
  • [7] Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure
    Watanabe, Shin
    Ishikawa, Kiyotake
    Fish, Kenneth
    Oh, Jae Gyun
    Motloch, Lukas J.
    Kohlbrenner, Erik
    Lee, Philyoung
    Xie, Chaoqin
    Lee, Ahyoung
    Liang, Lifan
    Kho, Changwon
    Leonardson, Lauren
    McIntyre, Maritza
    Wilson, Scott
    Samulski, R. Jude
    Kranias, Evangelia G.
    Weber, Thomas
    Akar, Fadi G.
    Hajjar, Roger J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (14) : 1744 - 1756
  • [8] Is myosin phosphatase regulated in vivo by inhibitor-1?: Evidence from inhibitor-1 knockout mice
    Carr, AN
    Sutliff, RL
    Weber, CS
    Allen, PB
    Greengard, P
    de Lanerolle, P
    Kranias, EG
    Paul, RJ
    JOURNAL OF PHYSIOLOGY-LONDON, 2001, 534 (02): : 357 - 366
  • [9] The Human G147D-Protein Phosphatase 1 Inhibitor-1 Polymorphism Is Not Associated with Altered Clinical Characteristics in Heart Failure
    Chen, Guoli
    Zhou, Xiaoyang
    Pathak, Anand
    Dorn, Gerald W., II
    Kranias, Evangelia G.
    CARDIOLOGY, 2009, 112 (03) : 224 - 231
  • [10] COMPARISON OF ADENOSINE AND MUSCARINIC RECEPTOR-MEDIATED EFFECTS ON PROTEIN PHOSPHATASE INHIBITOR-1 ACTIVITY IN THE HEART
    GUPTA, RC
    NEUMANN, J
    WATANABE, AM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (01): : 16 - 22
12345